Related Experiment Video

Updated: Jul 7, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation

Zhuo Zhang1, Ruiwen Zhang

  • 1Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

The EMBO Journal
|March 1, 2008
PubMed

Insights

PA28gamma acts as a cofactor, promoting MDM2-mediated p53 degradation and inhibiting apoptosis. Eliminating PA28gamma enhances p53 activity and cancer cell apoptosis, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • p53 tumor suppressor activity is inhibited by MDM2-mediated proteasomal degradation.
  • Mechanisms regulating the MDM2-p53 interaction remain incompletely understood.
  • PA28gamma, a proteasome activator, inhibits apoptosis via unknown pathways.

Purpose of the Study:

  • To elucidate the role of PA28gamma in the MDM2-p53 interaction.
  • To determine the mechanism by which PA28gamma influences apoptosis and cell proliferation.
  • To explore the therapeutic potential of targeting PA28gamma in cancer.

Main Methods:

  • Investigated PA28gamma's interaction with MDM2 and p53 using biochemical assays.
  • Assessed the effect of PA28gamma on p53 ubiquitination and proteasomal degradation.
  • Utilized human cancer cell lines with and without endogenous PA28gamma to evaluate apoptosis and p53 activity.

Main Results:

  • The polymer form of PA28gamma facilitates physical interaction between MDM2 and p53.
  • PA28gamma promotes MDM2-dependent p53 degradation, limiting p53 accumulation and inhibiting apoptosis.
  • Depletion of PA28gamma in cancer cells restores p53 activity and enhances apoptosis.

Conclusions:

  • PA28gamma functions as a cofactor in the MDM2-p53 interaction, promoting p53 degradation.
  • PA28gamma's mechanism involves facilitating p53 ubiquitination and proteasomal degradation.
  • Targeting PA28gamma levels could modulate p53 content and improve cancer therapy efficacy.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...